Andrew J. Fromkin, Director at Immunovant, Inc. (IMVT), sold 14,616 shares at $19.52 ($286K) on 2025-03-07, disclosed to the SEC on 2025-03-11.
Scheduled sale ($286k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.52 | 6,616 | $129K | 45.2% |
| 2 | $19.52 | 6,616 | $129K | 45.2% |
| 3 | $19.96 | 1,384 | $28K | 9.7% |
| Total | $19.56 avg | 14,616 | $286K | 100% |
| Filing → |
| IMVT | SELL | 2023-12-05 | $981K | — | Filing → |
| IMVT | BUY | 2021-08-11 | $43K | — | Filing → |